Literature DB >> 11451511

Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.

C Perez1, A Sanchez, D Putnam, D Ting, R Langer, M J Alonso.   

Abstract

The purpose of the present work was to produce and characterize poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) nanoparticles (size lower than 300 nm) containing a high loading of plasmid DNA in a free form or co-encapsulated with either poly(vinyl alcohol) (PVA) or poly(vinylpyrrolidone) (PVP). The plasmid alone or with PVA or PVP was encapsulated by two different techniques: an optimized w/o/w emulsion-solvent evaporation technique as well as by a new w/o emulsion-solvent diffusion technique. Particle size, zeta potential, plasmid DNA loading and in vitro release were determined for the three plasmid-loaded formulations. The influence of the initial plasmid loadings (5, 10, 20 microg plasmid DNA/mg PLA-PEG) on those parameters was also investigated. The plasmid loaded into the nanoparticles and released in vitro was quantified by fluorimetry and the different molecular forms were identified by gel electrophoresis. PLA-PEG nanoparticles containing plasmid DNA in a free form or co-encapsulated with PVA or PVP were obtained in the range size of 150-300 nm and with a negative zeta potential, both parameters being affected by the preparation technique. Encapsulation efficiencies were high irrespective of the presence of PVA or PVP (60-90%) and were slightly affected by the preparation technique and by the initial loading. The final plasmid DNA loading in the nanoparticles was up to 10-12 microg plasmid DNA/mg polymer. Plasmid DNA release kinetics varied depending on the plasmid incorporation technique: nanoparticles prepared by the w/o diffusion technique released their content rapidly whereas those obtained by the w/o/w showed an initial burst followed by a slow release for at least 28 days. No significant influence of the plasmid DNA loading and of the co-encapsulation of PVP or PVA on the in vitro release rate was observed. In all cases the conversion of the supercoiled form to the open circular and linear forms was detected. In conclusion, plasmid DNA can be very efficiently encapsulated, either in a free form or in combination with PVP and PVA, into PLA-PEG nanoparticles. Additionally, depending on the processing conditions, these nanoparticles release plasmid DNA either very rapidly or in a controlled manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451511     DOI: 10.1016/s0168-3659(01)00397-2

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  41 in total

1.  Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.

Authors:  Manoochehr Rasekh; Christopher Young; Marta Roldo; Frédéric Lancien; Jean-Claude Le Mével; Sassan Hafizi; Zeeshan Ahmad; Eugen Barbu; Darek Gorecki
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

Review 2.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 3.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

Review 4.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

5.  Synthesis of pegylated immunonanoparticles.

Authors:  Jean-Christophe Olivier; Ramon Huertas; Hwa Jeong Lee; Frederic Calon; William M Pardridge
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

6.  A novel, simple, and stable mesoporous silica nanoparticle-based gene transformation approach in Solanum lycopersicum.

Authors:  Zahra Hajiahmadi; Reza Shirzadian-Khorramabad; Mahmood Kazemzad; Mohammad Mehdi Sohani; Jahangir Khajehali
Journal:  3 Biotech       Date:  2020-08-03       Impact factor: 2.406

7.  Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Authors:  Toshihiro Kushibiki; Kunio Matsumoto; Toshikazu Nakamura; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

9.  Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.

Authors:  Zhijin Chen; Dexin Yu; Shaojie Wang; Na Zhang; Chunhong Ma; Zaijun Lu
Journal:  Nanoscale Res Lett       Date:  2009-03-18       Impact factor: 4.703

10.  Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.

Authors:  Weiwei Zou; Chunxi Liu; Zhijin Chen; Na Zhang
Journal:  Nanoscale Res Lett       Date:  2009-05-21       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.